Strides Receives USFDA Approval For Levetiracetam Oral Solution

Strides Receives USFDA Approval For Levetiracetam Oral Solution

The product is bioequivalent and therapeutically equivalent to the Reference Listed Drug (RLD), Keppra Oral Solution, 100 mg/mL of UCB, Inc. It is used in the treatment of seizures.

FPJ Web DeskUpdated: Tuesday, November 21, 2023, 11:17 AM IST
article-image
Strides Receives USFDA Approval For Levetiracetam Oral Solution |

Strides Pharma Science Limited (Strides) on Tuesday announced that its step‐down wholly owned subsidiary, Strides Pharma Global Pte. Limited, Singapore, has received approval for Levetiracetam Oral Solution USP, 100 mg/mL, from the United States Food & Drug Administration (USFDA), the company announced through an exchange filing.

The product is bioequivalent and therapeutically equivalent to the Reference Listed Drug (RLD), Keppra Oral Solution, 100 mg/mL of UCB, Inc. It is used in the treatment of seizures.

The Levetiracetam Oral Solution has a market size of ~US$55 Mn per IQVIA. The product will be manufactured at the company’s facility in Bengaluru.

The company has 260 cumulative ANDA filings (including the recently acquired portfolio from Endo at Chestnut Ridge) with USFDA, of which 230+ ANDAs have been approved. The company has set a target to launch ~ 60 new products over three years in the US.

Strides Pharma Science Limited shares

The shares of Strides Pharma Science Limited on Tuesday at 11:04 am IST were at Rs 507.65, up by 3.49 percent.

RECENT STORIES

India's April-October Fiscal Deficit Reaches ₹8.04 Lakh Crore; 45% Of FY24 target

India's April-October Fiscal Deficit Reaches ₹8.04 Lakh Crore; 45% Of FY24 target

Indian Defence Ministry Approves Procurement Of Additional 97 Tejas Jets For ₹65,000 Crore

Indian Defence Ministry Approves Procurement Of Additional 97 Tejas Jets For ₹65,000 Crore

Rupee Falls 7 Paise To Settle at 83.39 Against US Dollar

Rupee Falls 7 Paise To Settle at 83.39 Against US Dollar

Infosys Partners With Shell New Energies To Advance Immersion Cooling Services For Data Centers

Infosys Partners With Shell New Energies To Advance Immersion Cooling Services For Data Centers

Maharashtra Cabinet To Introduce Stamp Duty Abhay Yojana (Amnesty Scheme) 2023 To Increase Revenue

Maharashtra Cabinet To Introduce Stamp Duty Abhay Yojana (Amnesty Scheme) 2023 To Increase Revenue